March 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    March 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :

    • ANNOUNCES ITS INTENTION TO MAKE AN OFF-MARKET TAKEOVER OFFER TO ACQUIRE HEALIUS LIMITED
    • OFFER WILL BE MADE BY WAY OF AN OFF-MARKET TAKEOVER OFFER BY ACL TO ACQUIRE ALL OF HEALIUS SHARES ON ISSUE
    • ACL'S OFFER IS 0.74 ACL SHARES FOR EVERY 1 HEALIUS SHARE HELD
    • IF ACL SUCCESSFUL IN ACQUIRING ALL OF HEALIUS SHARES ON ISSUE UNDER OFFER, HEALIUS SHAREHOLDERS WILL HOLD ABOUT 68% OF ACL
    • ACL EXPECTS THAT ITS EBIT FOR FY23 WILL BE WITHIN RANGE OF A$68 MILLION AND A$74 MILLION
    • MATERIAL SYNERGY POTENTIAL OF A$95 MILLION BY BRINGING COMPANIES TOGETHER
    • POTENTIAL MERGED GROUP PRO FORMA FY23 EBIT OF A$361 MILLION INCLUDING EXPECTED COST SYNERGIES

    (([email protected];))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
84.5¢
Change
0.005(0.60%)
Mkt cap ! $613.5M
Open High Low Value Volume
83.5¢ 86.5¢ 81.5¢ $3.101M 3.675M

Buyers (Bids)

No. Vol. Price($)
1 9 84.5¢
 

Sellers (Offers)

Price($) Vol. No.
85.0¢ 49196 5
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
HLS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.